Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 24,234 $ 16,399
Collaborations receivable 50 0
Prepaids and other assets 956 1,269
Total current assets 25,240 17,668
Property and equipment, net 12 14
Total assets 25,252 17,682
Current liabilities:    
Accounts payable 1,496 1,214
Accrued expenses 1,203 1,971
Total current liabilities 2,699 3,185
Warrant liabilities 0 27,964
Total liabilities 2,699 31,149
Commitments and contingencies (Note 3)
Stockholders' equity (deficit)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of June 30, 2021 and December 31, 2020; no shares issued and outstanding at June 30, 2021 and December 31, 2020. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 16,891,855 and 10,882,495 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively. 2 1
Additional paid-in-capital 101,376 19,207
Accumulated deficit (78,825) (32,675)
Total stockholders' equity (deficit) 22,553 (13,467)
Total liabilities and stockholders' equity (deficit) $ 25,252 $ 17,682